Sugi Predict

Sugi Predict / Compounds / SCHEMBL213810

SCHEMBL213810

SCHEMBL213810

CCCCOC(=O)[C@H](C)N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ ATM Q13315 1/20 0.50
▸ TSHR P16473 5/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.44
▸ NAAA Q02083 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ SLC15A1 P46059 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181783 1.00 ALDH1A1 (0.54) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL624749 1.00 ALDH1A1 (0.54) ALDH1A1ATMTSHRHPGDHCAR2
Hydrochloric Acid SCHEMBL4380145 0.98 ALDH1A1 (0.52) ALDH1A1ATMTSHRHPGDHCAR2
Hydrochloric Acid SCHEMBL213809 0.98 ALDH1A1 (0.52) ALDH1A1ATMTSHRHPGDHCAR2
Hydrochloric Acid SCHEMBL4731637 0.98 ALDH1A1 (0.52) ALDH1A1ATMTSHRHPGDHCAR2
SCHEMBL18378673 0.93 NAAA (0.52) ALDH1A1ATMTSHRHCAR2NAAA
SCHEMBL4672442 0.93 NAAA (0.52) ALDH1A1ATMTSHRHCAR2NAAA
SCHEMBL253585 0.93 NAAA (0.52) ALDH1A1ATMTSHRHCAR2NAAA
SCHEMBL2382560 0.92 ALDH1A1 (0.47) ALDH1A1ATMTSHRHPGDHCAR2
Hydrochloric Acid SCHEMBL23510790 0.91 NAAA (0.50) ALDH1A1ATMTSHRHCAR2NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752174-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF University of Florida Research Foundation, Incorporated (US) 2020-12-23 — — EP claimed
WO-2019160910-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2019-08-22 — — WO claimed
CN-109836373-A A kind of environmentally friendly method prepared and circulation of tail gas utilizes of vitamin B6 新发药业有限公司 2019-06-04 — — CN claimed
CN-107849071-A antiviral β amino acid ester phosphorodiamidate compounds 默沙东公司 2018-03-27 — — CN claimed
CN-106244654-A A kind of enzyme transforming process prepares the method for L alanyl L alanine 精晶药业股份有限公司 2016-12-21 — — CN claimed
EP-0079767-A2 Amino acids and a process for preparing same EXXON RESEARCH AND ENGINEERING COMPANY (US) 1983-05-25 — — EP claimed
US-12590089-B2 Processes for preparing toll-like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2026-03-31 — — US disclosed
US-20260015373-A1 STAT6 MODULATORS AND USES THEREOF RECLUDIX PHARMA INC (US) 2026-01-15 — — US disclosed
EP-4630434-A1 PHOSPHORAMIDATE MONOSACCHARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS Surio Therapeutics Co. Ltd (CN) 2025-10-15 — — EP disclosed
US-20250288583-A1 Treatment of Mucus Hypersecretion ALTA RESEARCH, LLC 2025-09-18 — — US disclosed
US-20250215029-A1 STAT MODULATORS AND USES THEREOF RECLUDIX PHARMA, INC. 2025-07-03 — — US disclosed
CN-119080838-B Antiviral medicine and application thereof 上海柯君医药科技有限公司 2025-03-11 — — CN disclosed
CN-115175735-B Antiviral compounds 吉利德科学公司 2025-03-04 — — CN disclosed
EP-0079767-A2 Amino acids and a process for preparing same EXXON RESEARCH AND ENGINEERING COMPANY (US) 1983-05-25 — — EP disclosed
US-4376102-A AMINO ACID AS COSOLVENT EXXON RESEARCH AND ENGINEERING CO. (US) 1983-03-08 — — US disclosed
US-4376101-A Process for removing acid gases using a basic salt activated with a non-sterically hindered diamine EXXON RESEARCH AND ENGINEERING CO. (US) 1983-03-08 — — US disclosed
US-4246424-A IN PRESENCE OF ALKALI METAL AND POLYCYCLIC AROMATIC HYDROCARBON SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-01-20 — — US disclosed
US-4158016-A CONTACTING WITH AN ALKALI METAL POLYCYCLIC AROMATIC HYDROCARBON CATALYST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-06-12 — — US disclosed
US-3970700-A Racemization of optically active amines SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-07-20 — — US disclosed
US-3954845-A Synthetic detergents of the ampholytic betaine type, process for preparing the same and compositions MODOKEMI AKTIEBOLAG (SW) 1976-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590089-B2 Processes for preparing toll-like receptor modulator compounds TLR8, MYD88, TLR6 ALDH1A1 3917/4885ATM 494/4885TSHR 946/4885
US-20260015373-A1 STAT6 MODULATORS AND USES THEREOF STAT6, STAT5A, STAT3 ALDH1A1 2606/4885ATM 2365/4885TSHR 186/4885
US-20250215029-A1 STAT MODULATORS AND USES THEREOF STAT6, STAT3, STAT5A ALDH1A1 2707/4885ATM 694/4885TSHR 707/4885
US-20250288583-A1 Treatment of Mucus Hypersecretion TRPM8, GPR18, OPRL1 ALDH1A1 4313/4885ATM 2687/4885TSHR 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.